Skip to main content

AGC Pharma Chemicals is thrilled to announce its participation at CPHI Milan 2024, taking place from October 8-10. CPHI Milan unites industry leaders, pharma professionals and business of all sizes under one roof for three days of powerful connection and collaboration.

You’ll find us at Booth 5C121, where we will showcase our capabilities in Small Molecules, Intermediates development and production. Our team is eager to discuss how we can help accelerate your pharmaceutical projects, from process development to scale-up and manufacturing.

This event is the perfect opportunity to connect and explore how our expertise can add value to your API and intermediate projects. To make the most of your time at CPHI, we encourage you to schedule a meeting in advance with our experts. Let’s collaborate and bring your next innovation to the market faster and more efficiently.

Reach out to book a meeting and let’s explore new possibilities for your projects at CPHI Milan!

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend CPHI Japan 2026
8th April 2026

AGC Pharma Chemicals to Attend CPHI Japan 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
Events & ConventionsAGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026
31st March 2026

AGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026

Best in Class distinctions for Overall Staff, Cultural Fit, Technology Use, and Scaling Support. Recognition within the Small/Mid-Size Small Molecule API group. Barcelona, March 30, 2026 – AGC Pharma Chemicals has…
How Reactors Work in a CDMO for Small Molecule APIsAll of ArticlesCDMO ProcessesCDMO TechnologyHow Reactors Work in a CDMO for Small Molecule APIs
13th March 2026

How Reactors Work in a CDMO for Small Molecule APIs

In a pharmaceutical Contract Development and Manufacturing Organization (CDMO), reactors are the foundational equipment where chemical reactions convert raw materials into intermediates and Active Pharmaceutical Ingredients (APIs) under tightly controlled…